Ewid M, Sherif H, Billah SMB, et al. – Researchers assessed glycated hemoglobin (HbA1c) as a predictor of coronary artery disease (CAD) in low-risk profile non-diabetic patients living in the Al Qassim region of Saudi Arabia. The study sample consisted of 38 patients without a history of CAD who provided demographic data and HbA1c estimations. All patients completed coronary computed tomography angiography (CCTA) for chest pain assessment. Overall, the investigators found that glycated hemoglobin may be a predictive biomarker for CAD in non-diabetic low-risk patients.